0001415889-24-016087.txt : 20240607
0001415889-24-016087.hdr.sgml : 20240607
20240607205527
ACCESSION NUMBER: 0001415889-24-016087
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240605
FILED AS OF DATE: 20240607
DATE AS OF CHANGE: 20240607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Patni Rajiv
CENTRAL INDEX KEY: 0001616200
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38890
FILM NUMBER: 241031288
MAIL ADDRESS:
STREET 1: C/O OCERA THERAPEUTICS, INC.
STREET 2: 525 UNIVERSITY AVENUE, SUITE 610
CITY: PALO ALTO
STATE: CA
ZIP: 94301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quince Therapeutics, Inc.
CENTRAL INDEX KEY: 0001662774
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 901024039
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-910-5717
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD., SUITE 273
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Cortexyme, Inc.
DATE OF NAME CHANGE: 20160104
4
1
form4-06082024_120623.xml
X0508
4
2024-06-05
0001662774
Quince Therapeutics, Inc.
QNCX
0001616200
Patni Rajiv
C/O QUINCE THERAPEUTICS, INC.
611 GATEWAY BLVD, SUITE 273
SOUTH SAN FRANCISCO
CA
94080
true
false
false
false
0
Employee Stock Option (right to buy)
0.82
2024-06-05
4
A
0
13500
0
A
2025-06-05
2034-06-05
Common Stock
13500
13500
D
100% of the shares subject to this stock option will vest on the one-year anniversary of the grant date.
/s/ Brendan Hannah, Attorney-in-Fact for Rajiv Patni
2024-06-07